Clinical Trials in New York State

Showing 16861-16880 of 17,167 trials

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

NCT00525954

The study will be conducted at up to 25 U.S. centers and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 2 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.

Coronary Artery Disease

Anthera Pharmaceuticals120 participantsStarted Sep 2007

Mobile, Alabama, United States • Scottsdale, Arizona, United States • Hudson, Florida, United States +10 more locations

COMPLETEDPhase 462 miles

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

NCT00366002

This study will evaluate safety, efficacy and patient's perception of outcome after treatment with darifenacin (7.5 mg once daily (o.d.) with voluntary increase up to 15 mg o.d.) in patients with OAB who are dissatisfied with prior oxybutynin extended release (ER) or tolterodine extended release (ER) therapy.

Overactive Bladder (OAB)

Novartis500 participantsStarted Jun 2006

Birmingham, Alabama, United States • Chandler, Arizona, United States • Mesa, Arizona, United States +79 more locations

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder

Find Trials by Condition in New York State

Study of Rebamipide Eye Drops to Treat Dry Eye

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects

INSIGHTS ICD Registry

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

Etanercept for Wegener's Granulomatosis

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux Disease

Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results